Padmanee Sharma

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Anirban Maitra · 2 shared papers, 2019–2024 · strength 0.24
   • Paper TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoin… DOI 10.1038/s41467-024-49189-x↗
   • Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
2. Dung Thi Le · 1 shared paper, 2024 · strength 0.20
   • Paper Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pa… DOI 10.1136/jitc-2023-007883↗
3. Eileen Mary O'Reilly · 1 shared paper, 2024 · strength 0.20
   • Paper Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pa… DOI 10.1136/jitc-2023-007883↗
4. Margaret K. Callahan · 1 shared paper, 2024 · strength 0.20
   • Paper Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pa… DOI 10.1136/jitc-2023-007883↗
5. Michael Andrew Morse · 1 shared paper, 2024 · strength 0.20
   • Paper Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pa… DOI 10.1136/jitc-2023-007883↗
6. Swetha Anandhan · 1 shared paper, 2024 · strength 0.17
   • Paper TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoin… DOI 10.1038/s41467-024-49189-x↗
7. Jimin Min · 1 shared paper, 2024 · strength 0.17
   • Paper TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoin… DOI 10.1038/s41467-024-49189-x↗
8. Michael James Overman · 1 shared paper, 2019 · strength 0.07
   • Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
9. Matthew H. G. Katz · 1 shared paper, 2019 · strength 0.07
   • Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
10. Chantale Bernatchez · 1 shared paper, 2019 · strength 0.07
    • Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
11. Huamin Wang · 1 shared paper, 2019 · strength 0.07
    • Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
12. Jennifer Ann Wargo · 1 shared paper, 2019 · strength 0.07
    • Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
13. Jorge M. Blando · 1 shared paper, 2019 · strength 0.07
    • Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
14. Cassian Yee · 1 shared paper, 2019 · strength 0.07
    • Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
15. Gauri Rajani Varadhachary · 1 shared paper, 2019 · strength 0.07
    • Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗
16. Christine A. Iacobuzio–Donahue · 1 shared paper, 2019 · strength 0.07
    • Paper Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic… DOI 10.1073/pnas.1811067116↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.